Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
BMC Gastroenterology
|
May 9, 2021
Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study
Hsu-Heng Yen, Pei-Yuan Su, I-L Ing Liu, et al.
Hepatology International
|
September 25, 2015
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
Chia-Chi Wang, Chih-Lin Lin, Tsai-Yuan Hsieh, et al.
Frontiers in Neuroimaging
|
November 10, 2025
A Bayesian deep segmentation framework for glioblastoma tumor segmentation using follow-up MRIs
Tanjida Kabir, Kang-Lin Hsieh, Luis Nunez, et al.
Archives of Virology
|
July 17, 2013
Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
Ming-Tsung Lin, Yeh-Pin Chou, Tsung-Hui Hu, et al.
Plos One
|
August 14, 2020
Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, et al.
Cancers
|
October 26, 2024
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis
Yu-Chun Hsu, Po-Ting Lin, Wei Teng, et al.
American Journal of Cancer Research
|
December 7, 2023
A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefit
Chung-Wei Su, Wei Teng, Po-Ting Lin, et al.
PLOS Digital Health
|
April 10, 2024
Deep learning to predict rapid progression of Alzheimer's disease from pooled clinical trials: A retrospective study
Xiaotian Ma, Madison Shyer, Kristofer Harris, et al.
Scientific Reports
|
April 25, 2025
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy
Xiaotian Ma, Yu-Chun Hsu, Amma Asare, et al.
American Journal of Cancer Research
|
April 9, 2024
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor
Po-Ting Lin, Yu-Chun Hsu, Yu-Ting Kao, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
BMC Gastroenterology
|
May 9, 2021
Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study
Hsu-Heng Yen, Pei-Yuan Su, I-L Ing Liu, et al.
Hepatology International
|
September 25, 2015
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
Chia-Chi Wang, Chih-Lin Lin, Tsai-Yuan Hsieh, et al.
Frontiers in Neuroimaging
|
November 10, 2025
A Bayesian deep segmentation framework for glioblastoma tumor segmentation using follow-up MRIs
Tanjida Kabir, Kang-Lin Hsieh, Luis Nunez, et al.
Archives of Virology
|
July 17, 2013
Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
Ming-Tsung Lin, Yeh-Pin Chou, Tsung-Hui Hu, et al.
Plos One
|
August 14, 2020
Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, et al.
Cancers
|
October 26, 2024
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis
Yu-Chun Hsu, Po-Ting Lin, Wei Teng, et al.
American Journal of Cancer Research
|
December 7, 2023
A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefit
Chung-Wei Su, Wei Teng, Po-Ting Lin, et al.
PLOS Digital Health
|
April 10, 2024
Deep learning to predict rapid progression of Alzheimer's disease from pooled clinical trials: A retrospective study
Xiaotian Ma, Madison Shyer, Kristofer Harris, et al.
Scientific Reports
|
April 25, 2025
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy
Xiaotian Ma, Yu-Chun Hsu, Amma Asare, et al.
American Journal of Cancer Research
|
April 9, 2024
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor
Po-Ting Lin, Yu-Chun Hsu, Yu-Ting Kao, et al.
Page
of 8